Results 91 to 100 of about 4,373 (200)

Lambert-Eaton Myasthenia Syndrome Initial Presentation Mimicking Myasthenia Gravis

open access: yes, 2023
The neuromuscular junction disorders myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) both present with muscle weakness but usually have clinical features that distinguish the 2 disorders (1-3)
S. Y. Uhm; H. Nguyen; K. P. Kanakia; J. E. Carter
core  

Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases

open access: yesArquivos de Neuro-Psiquiatria, 2010
Lambert-Eaton myasthenic syndrome (LEMS) is an immune-mediated disorder of the presynaptic neuromuscular transmission, which more frequently occurs as the remote effect of a neoplasm, in the paraneoplastic form (P-LEMS), or in a non-paraneoplastic form ...
Paulo J. Lorenzoni   +4 more
doaj   +1 more source

LAMBERT-EATON MYASTHENIC SYNDROME

open access: yesVestnik, 2022
Миастенический Синдром Ламберта-Итона (МСЛИ) - это нервно-мышечное заболевание, характеризующееся образованием антител к потенциалзависимым кальциевым каналам (ПЗКК), триггером которых является опухолевый процесс (чаще всего мелкоклеточный рак легких) или как первичный аутоиммунный процесс.
openaire   +1 more source

Clinical features of neuromuscular disorders in patients with N-type voltage-gated calcium channel antibodies

open access: yesEuropean Journal of Translational Myology, 2016
Neuromuscular junction disorders affect the pre- or postsynaptic nerve to muscle transmission due to autoimmune antibodies. Members of the group like myasthenia gravis and Lambert-Eaton syndrome have pathophysiologically distinct characteristics. However,
Andreas Totzeck   +3 more
doaj   +1 more source

Electrophysiological study in neuromuscular junction disorders

open access: yesAnnals of Indian Academy of Neurology, 2013
This review is on ultrastructure and subcellular physiology at normal and abnormal neuromuscular junctions. The clinical and electrophysiological findings in myasthenia gravis, Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes ...
Ajith Cherian   +2 more
doaj   +1 more source

An Ocular Myasthenic Syndrome

open access: yes, 1987
Bilateral ptosisA 15-month old male developed droopy eyelids the day he suffered minor head trauma. Subsequently, over a 2-week period lethargy and fatigue were manifest.A neurological exam, Tensilon and neostigmine tests, and EMG\u27s were reported to ...
Mark J. Kupersmith, MD; R. Reuben; M. Gelwan, M. A. Greco; D. Ma; F. Warren
core  

Lambert-Eaton myasthenic syndrome and polyneuropathy in a patient with epidermoid carcinoma of the lung

open access: yes, 1993
We describe a patient affected by the Lambert-Eaton myasthenic syndrome, sensory motor axonal neuropathy and epidermoid carcinoma of the lung. Serum autoantibodies to voltage-operated calcium channels were detected.
M. Comola   +8 more
core   +1 more source

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)

open access: yes, 2013
Autoantibodies to different subtypes of the voltage-gated calcium channel (VGCC) have been described in two very different neurological syndromes, the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS).
Maddison, P   +4 more
core   +1 more source

Síndrome de Lambert-Eaton paraneoplásico en carcinoma de células pequeñas de pulmón

open access: yes, 2020
Lambert Eaton myasthenic syndrome is a paraneoplastic autoimmune pathology mostly associated with lung cancer, which manifests itself with involvement of the neuromuscular junction and autonomic dysfunctions.
González Houdelath, Karolina   +4 more
core   +1 more source

Treatment for Lambert-Eaton myasthenic syndrome

open access: yes
Background Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission. Treatments attempt to overcome the harmful autoimmune process, or improve residual neuromuscular transmission Objectives The objective was to ...
Maddison P, Sedehizadeh S, Keogh M
core  

Home - About - Disclaimer - Privacy